EMPALIX 25
EMPALIX 25 contains Empagliflozin 25 mg, a higher-strength SGLT2 inhibitor used for better control of type 2 diabetes. It works by increasing glucose excretion through urine, helping reduce blood sugar levels effectively. Along with glycemic control, it supports weight management and offers proven cardiovascular and kidney protection, making it a suitable choice for patients needing stronger and long-term diabetes care.
About brand
Parturient ut id tellus vulputatre ac ultrlices a part ouriesnt sapien dignissim partu rient a a inter drum vehicula. Ornare metus laoreet tincidunt eros rolem tristique pretium malada.
Cras rhoncus vivamus luctus platea arcu laoreet selm. Curae est condenectus sed hac a parturient vestibulum.
Related products
SITPIN 100
SITPIN 100 contains Sitagliptin 100 mg, a DPP-4 inhibitor used to manage blood sugar levels...
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
LINANTA M 1000
LINANTA M 1000 contains Linagliptin 2.5 mg + Metformin Hydrochloride 1000 mg, a powerful combination...
LINANTA M 500
LINANTA M 500 combines Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg, offering dual-action support...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination therapy used for effective management of type 2...
DUET ACT 2 FORTE
DUET ACT 2 FORTE Tablet is a combination medicine used for effective management of type...
CARBOSTOP 50
CARBOSTOP 50 Tablet is a combination medicine used for managing type 2 diabetes effectively. It...
CARBOSTOP 25
CARBOSTOP 25 Tablet is a combination medicine used to manage type 2 diabetes. It contains...
